Central nervous system (CNS) disorders affect as many as 1.5 billion people globally. The
limited delivery of most imaging and therapeutic agents into the brain is a major challenge …

Magnetic drug targeting is a method by which magnetic drug carriers in the body are
manipulated by external magnetic fields to reach the target area. This method is potentially …

Magnetically actuated soft robots may improve the treatment of disseminated intravascular
coagulation. Significant progress has been made in the development of soft robotic systems …

The main factors of Alzheimer's disease (AD) are the cerebral accumulation and the
formation of extracellular amyloid plaques. The Aβ peptides are highly able to accumulative …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease,
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …

Superparamagnetic iron oxide nanoparticles (SPIONs) have been widely employed in
biomedical fields, including targeted delivery of antitumor therapy. Conventional magnetic …

Photocatalyst is the most widespread method in advanced oxidation technologies, but due
to the photo-induced electron combine easily with hole and the wavelength of adsorption is …

Alzheimer's disease (AD) is a progressive and fatal neurodegenerative condition and the
most prevalent cause of dementia. This disease is characterized by progressive cognitive …

Nanocarriers (synthetic/cell-based have attracted enormous interest for various therapeutic
indications, including neurodegenerative disorders. A broader understanding of the impact …